Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,547,436
+$1,614,801 QoQ
Shares Held
238,403
+4.4% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 294 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Derivatives in BHVN
reported options exposure · as of Jun 30, 2026CallValue
$1,270,752
CallShares
85,400
PutValue
$775,248
PutShares
52,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. BHVN ranks #41 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in BHVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,270,752 | 85,400 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $3,547,436 | 238,403 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $775,248 | 52,100 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $135,360 | 16,000 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $1,076,112 | 127,200 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $1,932,635 | 228,444 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $9,478,146 | 839,517 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $1,411,250 | 125,000 | Call | Defined | 2026-02-12 | |
| 2025-09-30 | $11,997,161 | 799,278 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $1,283,355 | 85,500 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $522,348 | 34,800 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $3,749,745 | 265,751 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $643,416 | 45,600 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $1,914,727 | 135,700 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $1,190,989 | 49,542 | Shares | Defined | 2025-05-19 | |
| 2025-03-31 | $1,396,724 | 58,100 | Call | Defined | 2025-05-19 | |
| 2024-12-31 | $590,130 | 15,800 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $885,195 | 23,700 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $399,760 | 8,000 | Put | Defined | 2024-11-15 | |
| 2024-09-30 | $2,123,725 | 42,500 | Call | Defined | 2024-11-15 | |
| 2024-09-30 | $1,747,700 | 34,975 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $12,095,705 | 348,479 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $11,497,587 | 210,232 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $5,340,327 | 124,774 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $715,301 | 27,501 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $5,422,352 | 226,687 | Shares | Defined | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||